Bayer Statement on Availability of Factor VIII Products Amid 2019-nCoV (Novel Coronavirus)

Bayer has issued the following statement regarding the supply and availability of Bayer’s Factor VIII/Hemophilia A products in the wake of the 2019-nCoV (novel coronavirus) outbreak: